Single-cell analysis of colonic epithelium reveals unexpected shifts in cellular composition and molecular phenotype in treatment-naïve adult Crohn’s disease

Matt Kanke,Meaghan M. Kennedy,Sean Connelly,Matthew Schaner,Michael T. Shanahan,Elisabeth A. Wolber,Caroline Beasley,Grace Lian,Animesh Jain,Millie D. Long,Edward L. Barnes,Hans H. Herfarth,Kim L. Isaacs,Jonathan J. Hansen,Muneera Kapadia,José Gaston Guillem,Terrence S. Furey,Shehzad Z. Sheikh,Praveen Sethupathy
DOI: https://doi.org/10.1101/2021.01.13.426602
2021-01-15
Abstract:Abstract The intestinal epithelial barrier is comprised of a monolayer of specialized intestinal epithelial cells (IECs) that are critical in maintaining gut mucosal homeostasis. Dysfunction within various IEC fractions can increase intestinal permeability, resulting in a chronic and debilitating condition known as Crohn’s disease (CD). Defining the molecular changes in each IEC type in CD will contribute to an improved understanding of the pathogenic processes and the identification of potential therapeutic targets. Here we performed, for the first time at single-cell resolution, a direct comparison of the colonic epithelial cellular and molecular landscape between treatment-naïve adult CD and non-IBD control patients. Our analysis revealed that in CD patients there is a significant skew in the colonic epithelial cellular distribution away from canonical LGR5 + stem cells, located at the crypt-bottom, and toward one specific subtype of mature colonocytes, located at the crypt-top. Further analysis revealed unique changes to gene expression programs in every major cell type, including a previously undescribed suppression in CD of most enteroendocrine driver genes as well as L-cell markers including GCG . We also dissect a previously poorly understood SPIB + cell cluster, revealing at least four sub-clusters that exhibit unique features. One of these SPIB + sub-clusters expresses crypt-top colonocyte markers and is significantly up-regulated in CD, whereas another sub-cluster strongly expresses and stains positive for lysozyme (albeit no other canonical Paneth cell marker), which surprisingly is greatly reduced in expression in CD. Finally, through integration with data from genome-wide association studies, we show that genes implicated in CD risk exhibit heretofore unknown cell-type specific patterns of aberrant expression in CD, providing unprecedented insight into the potential biological functions of these genes.
What problem does this paper attempt to address?